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Abstract
Background: The United Nations’ Millennium Development Goals call for improving maternal and child health
status. Their progress, however, has been minimal and uneven across countries. The continuum of care is a key to
strengthening maternal, newborn, and child health. In this context, the Japanese government launched the Ghana
Ensure Mothers and Babies Regular Access to Care (EMBRACE) Implementation Research Project in collaboration
with the Ghanaian government. This study aims to evaluate the implementation process and effects of an
intervention to increase the continuum of care for maternal, newborn, and child health status in Ghana.
Methods/Design: We will conduct a cluster randomized controlled trial using an effectiveness-implementation
hybrid design in Dodowa, Kintampo, and Navrongo, Ghana. We will provide an intervention package to women
living in randomly allocated intervention clusters. The study population is women of reproductive age between
the ages of 15 and 49 years. The package includes: 1) use of a new continuum of care card, 2) continuum of care
orientation for health workers, 3) 24-hour health facility retention of mothers and newborns after delivery, and 4)
postnatal care by home visits. We will measure maternal, newborn, and child health outcomes for both intervention
and implementation impacts. The intervention outcomes are continuum of care completion rate, rate of postnatal
care within 48 hours, complication rate requiring mothers' and newborns' hospitalizations, and perinatal and
neonatal mortality. The implementation outcomes are intervention coverage of the target population, intervention
adoption and fidelity, implementation cost, and sustainability.
Discussion: In this trial, we will investigate how successful continuum of care can contribute to improving
maternal, newborn, and child health outcomes. If successful, this model will then be implemented further in Ghana
and other neighboring countries.
Trial registration: Current Controlled Trials ISRCTN90618993. Registered on 3 September 2014.
Keywords: Continuum of Care, Maternal, Newborn, and Child Health Outcomes, Ghana
* Correspondence: mjimba@m.u-tokyo.ac.jp
1Department of Community and Global Health, Graduate School of
Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033,
Japan
Full list of author information is available at the end of the article
TRIALS
© 2015 Kikuchi et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Kikuchi et al. Trials  (2015) 16:22 
DOI 10.1186/s13063-014-0539-3
Background
The United Nations’ Millennium Development Goals
(MDGs) 4 and 5 seek to improve maternal, newborn, and
child health (MNCH) status. Their progress, however, has
been minimal [1-4] and uneven across countries, espe-
cially in Sub-Saharan Africa [5-8]. Unless drastic improve-
ment is attained, most countries in Sub-Saharan Africa
will not meet MDGs 4 and 5 [5].
In this context, global health agencies have advocated
continuum of care (CoC) as a new paradigm to over-
come MNCH challenges [9,10]. The term CoC is well
known in nursing for palliative [11,12] and mental health
care [13]. In the public health area, the concept of CoC
has been used in HIV and AIDS care [12,14], linking
HIV diagnosis, care initiation, therapy retention, and low
viral load maintenance. However, for MNCH, the defin-
ition of CoC has not yet been clearly established, al-
though several attempts have been made [11,15-17]. So
far, CoC has been explained by sequential time and space
dimensions of MNCH activities. The time dimension lasts
from pre-pregnancy for women through childhood. The
space dimension links homes and communities through
health facilities [17].
The CoC in MNCH provided a framework to improve
health care for both women and their children by imple-
menting integrated interventions [11,18]. Such interven-
tion packages addressed different time stages in the CoC
[19-21]. Additionally, single interventions were also effica-
cious for both women and their children [18]. Examples
include newborn care preparedness by community-based
approaches [22,23], use of insecticide-treated nets in preg-
nancy [24], and iron-folic acid supplementation [25,26].
Furthermore, financially focused strategies attempted to
increase the demand for MNCH health services [27-30].
In the space dimension, the emphasized linkage is be-
tween the home and the first-level facility or the hospital.
In most African countries, newborns are vulnerable to care
delays and many newborn deaths occur at home [31].
Thus, interventions provided appropriate care at home,
strengthened health system supports, and improved house-
hold and community practices and actions [32]. For both
women and children, positive impacts were identified by
training traditional birth attendants [33] and increasing
emergency referral systems in the community [34]. Al-
though these interventions improved MNCH outcomes,
long-term sustainability remains a challenge [35], and it
is unclear whether they were effective in ‘real-world’ set-
tings. To make the best use of the available interventions,
we need to know how they work in such settings [36].
Moreover, it is unclear whether health outcomes will
be improved by filling the gaps in the CoC. A study
estimated that neonatal mortality would be reduced by
between 36 and 67% if all standard MNCH care pack-
ages (such as the antenatal care (ANC) package, skilled
maternal and immediate newborn care package, and emer-
gency obstetric care package) covered 90% of pregnant
women [37,38]. However, evidence-based studies are scarce
that demonstrate the effectiveness of improved CoC on
health outcomes by addressing these gaps.
In 2010, the Japanese government presented new global
health initiatives at the United Nations High-Level Plenary
Meeting on MDGs [39]. The statement expressed a strat-
egy to accelerate Japan’s concerted efforts to help achieve
health-related MDGs in developing countries, particularly
for maternal and child health [40]. The initiative com-
prised a model program, the Ghana Ensure Mothers and
Babies Regular Access to Care (EMBRACE) program. This
program exploits a package of effective interventions to
improve the health of mothers and children through the
CoC approach. A special feature of the initiative was the
Japanese government’s clear intention to implement an
‘evidence-based intervention’ [41]. To extend the benefits
of the Ghana EMBRACE initiative and evidence-based
practices in health policy, the Ghana EMBRACE
Implementation Research Project was launched in 2012
[42,43]. The project team comprised researchers from
the University of Tokyo and the Ghana Health Service
(GHS), including Dodowa, Kintampo, and Navrongo
Health Research Centres (HRC). Based on formative re-
search results, the project team developed interventions
and will implement them in three Health and Demo-
graphic Surveillance System (HDSS) sites in Ghana.
Ghana is one of the countries that face a significant
challenge to improving MNCH status [8,44-46]. Although
it has made progress in different HDSS sites [47-52],
according to the currently available evidence, Ghana is not
on track to meet these MDGs [53]. In particular, MNCH
status is poor in remote areas [47,49], and care-seeking
decisions are delayed for ill mothers and children [54,55].
Neonatal death is associated with maternal factors such as
multiple gestations and inadequate birth spacing [56].
Additionally, mothers and children do not use all MNCH
services continuously. In particular, mothers pay less at-
tention to newborn care. In almost half of home
deliveries, postnatal care (PNC) was not completed [45].
Approximately 40% of mothers who delivered at home re-
ported that they received PNC for themselves, while only
16% reported receiving it for their newborns [57]. How-
ever, when mothers appropriately used the antenatal, de-
livery, and postnatal health services, the risk of neonatal
death was reduced [56].
MNCH is often influenced by a complex interaction of
economic, financial, social, cultural, and clinical factors.
Ghana has multiple localities formed by the particular
characteristics of each area. Poor infrastructure often
limits access to emergency care [55]. In certain areas, a
traditional illness, asram, could be one cause of care-
seeking delay for ill children [58]. The diversity of local
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characteristics implies the need for flexibility in health
service provision [59,60]. This explains why implementa-
tion trials should be conducted in Ghana in different ac-
tual settings.
This study proposes specific objectives for the inter-
vention and implementation phases. The intervention
objective is to evaluate the impact of increased CoC com-
pletion on MNCH status in Ghana. The implementation
objective is to evaluate intervention acceptability in differ-
ent settings in Ghana.
In light of pragmatic situations in the intervention set-
tings, we included the following as CoC components:
1. ANC delivered at least four times by MNCH health
service providers at a health facility, in the
community, or at home;
2. Delivery assisted by skilled birth attendants (SBAs); and
3. PNC delivered three times by MNCH health service
providers at a health facility, in the community,
or at home, within 48 hours, at seven days, and
at six weeks postpartum.
Methods/Design
Study design
We will conduct a cluster randomized controlled trial using
an effectiveness-implementation hybrid design [36,61,62].
In this study design, we will assess the effects of both an
intervention package and its implementation process. An
effectiveness-implementation hybrid trial is an innovative
design to shorten the time from intervention development
through its implementation in a real-world setting [63,64].
This study design is categorized into three types. The type
one design focuses on testing the intervention while ob-
serving or gathering information on the implementation.
The type two design simultaneously tests the intervention
and its implementation strategy. The type three design
focuses more on testing implementation strategy while
observing or gathering information on intervention out-
comes [61]. In our study, we will adopt the type two
hybrid design to determine both the impact of the inter-
vention on CoC completion in MNCH and the accept-
ability of the implementation strategy by GHS.
This design will assess the effectiveness of intervention
and implementation by using cluster randomized alloca-
tion to divide participants into intervention and control
arms. For trial sustainability and scalability, we will con-
sider site-specific contexts in designing interventions [59].
We will conduct the study in three stages: baseline, imple-
mentation, and follow-up phases. Acceptability of the trials
will also be evaluated through monitoring ongoing trials.
Study site
We will conduct the study at three different sites in Ghana;
Dodowa (Greater Accra region), Kintampo (Brong-Ahafo
region), and Navrongo (Upper East region), where the
GHS runs HDSS sites (Figure 1). These three sites were se-
lected because highly reliable HDSS data are available.
HDSS involves semi-annual recording of vital demographic
events occurring among residents of all households in the
HDSS area: pregnancies, births, deaths, and migration.
Other data are also collected and updated regularly, such
as economic status, morbidity, and vaccination.
At the Dodowa HDSS site, the population was approxi-
mately 115,000 in 2011. It is located about 40 kilometers
away from Accra [65]. Consequently, pregnant women from
this site often prefer to deliver at health facilities in Accra.
Service deliveries are challenging since the site land size
covers about 40.5% of the Greater Accra region. Most of
the communities are scattered, containing small populations
[65,66].
At the Kintampo HDSS site, the surveillance population
was approximately 200,000 in 2011. This site is a multi-
ethnic area and farming is the most important economic
activity. Apart from the central area, most villages are not
supplied with electricity and are reached by dirt roads.
Access to health facilities is a challenge in Kintampo
[65,67], and a home delivery is often the first choice [68].
At the Navrongo HDSS site, the surveillance population
was approximately 153,000 in 2011 [65,69]. Navrongo is
the first area where the Community-based Health Planning
and Services (CHPS) program was launched in Ghana. In
that context, Community Health Officers (CHOs) have
contributed to improving health status in communities.
Among the three HDSS sites, only Navrongo is on track to
achieve MDG 5 [48].
As the MNCH services are national priority areas in
Ghana, various MNCH interventions have been imple-
mented in the three HDSS sites. Representative inter-
ventions include Mobile Technology for Community
Health (MoTeCH, between 2009 and 2012) [70], Quality
of prenatal and maternal care (Qualmat, between 2009
and 2014) [71], and Ghana Essential Health Interven-
tions Programme (GEHIP, between 2009 and 2014) [72]
in Navrongo; early neonatal vitamin A supplementation
in improving child survival (Neovita, between 2010 and
2012) [73], and Newborn home intervention study project
(Newhints, between 2008 and 2010) [74] in Kintampo;
and the conditional cash transfer project (GLST, between
2009 and 2014) [75] and Neonatal Quality Improvement
Programme (NQIP, between 2011 and 2012) in Dodowa.
Randomization and allocation
Each HDSS site contains two districts, and the districts
comprise multiple sub-districts, which are the minimum
health administration units in Ghana. We defined the
sub-district as a cluster unit. Only Jema and Dumso
(which used to be a part of Jema) sub-districts in the
Kintampo site were combined to form a cluster. In the
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three HDSS sites, a total of 36 sub-districts were in-
cluded. Of them, we excluded four sub-districts of Nav-
rongo where another MNCH project is planned. In total,
we chose 32 clusters for our study targets (Figure 2):
eight clusters in Dodowa, 12 clusters in Kintampo, and
12 clusters in Navrongo. We allocated half of the sub-
districts to the intervention arm and the other half to
the control arm. At least one hospital was allocated to
the intervention arm in each site, since the majority of
facility deliveries are done in hospitals (Table 1). Due to
the nature of the intervention, masking was not feasible.
We matched the clusters within the site before
randomization in the following aspects: population, number
of deliveries in each cluster, and number of midwives avail-
able. Cluster randomization was preferred over individual-
level randomization to minimize contamination, and also
for the pragmatic purposes of a future scale-up of the inter-
vention. The clusters were randomized by a data analyst,
who was not a primary member of the study team, using
computer-generated random sequences.
Study population and selection criteria
Our study population is women of reproductive age
between the ages of 15 and 49 years who live in the
areas covered by the Dodowa, Kintampo, and Navrongo
HDSS sites. Participants will be women who have given
birth in the study area between 1 September 2012 and
30 June 2014 for the baseline period, and between 1
October 2014 and 30 September 2015 for the trial
period. Exclusion criteria for the trials are women who
refuse to participate in the intervention. We expect only
a few women will meet it as the interventions will be
implemented within the current service delivery sys-
tem. In other words, they will receive the interven-
tions unless they refuse national standard MNCH
services. Exclusion criteria for the impact evaluations
are those who decline to be interviewed or who have
migrated out of the HDSS sites. We will also involve
health service providers in the intervention to provide
CoC services and to educate participant women in the
CoC concept.
Figure 1 Map of health and demographic surveillance system sites. Ghana has health and demographic surveillance system (HDSS) sites in
Dodowa, Kintampo, and Navrongo. The HDSS areas involve highly reliable semi-annual recording of vital demographic events occurring in
residents of all households.
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Recruitment and consent of participants
We will deliver the interventions to all eligible women
in the intervention arm. MNCH service providers will
approach them when receiving MNCH care at health
facilities or home. The expected recruitment period will
be from August to September 2014 for the baseline
survey, from October 2014 to September 2015 for the
intervention, and from October to November 2015 for
the follow-up survey. We will request informed consent
form signatures from the survey participants. Addition-
ally, we will obtain participants’ oral consent at their
intervention entry point. Their participation will be
voluntary and they are free to join or withdraw at any
time.
The Ghana EMBRACE interventions
Development of an intervention package
We developed a package of interventions based on a
formative research survey conducted in three different
HDSS sites (Table 2). In the survey, we identified the
gaps, barriers, and promoters of service reception in
continuous MNCH care. To address the actual MNCH
conditions in Ghana and site-specific cultural differ-
ences in delivery location, geographic conditions, and
health system capacity, we developed the following four
interventions: the utilization of the CoC card (A-1),
CoC orientation (A-2), 24-hour health facility retention
of mothers and newborns after delivery (B-1), and PNC
by home visits (B-2). We will implement A-1, A-2, and
B-2 interventions in all three HDSS sites. However, B-1
will be implemented only in Dodowa and Navrongo
because the number of midwives is not enough in
Kintampo.
In the control arm, Ghanaian government will provide
conventional MNCH services. In most of the primary
level health facilities, basic MNCH services will be pro-
vided. The delivery and laboratory services are provided
mainly in the secondary and tertiary level health facilities.
ANC services include general check-ups for mothers, urine
tests, hemoglobin tests, prevention of mother-to-child
transmission (PMTCT) of HIV, nutritional support, tetanus
toxoid immunization, and health education for birth pre-
paredness and maternal complications. Delivery services
include skilled delivery, facility referral, and emergency ob-
stetric care. PNC services include general check-ups for
mothers and children, body weights, infant vaccinations,
hemoglobin tests, nutritional support, health education for
breastfeeding and child care, and family planning counsel-
ling. Home visit check-ups are also provided, however,
home visit PNC within 48 hours is poorly adopted.
A-1 Utilization of the continuum of care card
In addition to the maternal health record book, health
service providers will provide the MNCH CoC card to
all women who receive ANC, delivery, and PNC assisted
by SBAs (Table 3). When these women receive follow-up
services, health service providers place a sticker on the
Table 1 Number of facilities (As of June 2014)
HDSS site Arm Hospital Health
center
Functional
CHPS zone
Private
Dodowa Intervention 1 1 13 5
Control 0 3 21 4
Kintampo Intervention 1 2 19 5
Control 1 4 22 0
Navrongo Intervention 1 3 18 4
Control 0 3 18 0
CHPS, Community-based Health Planning and Services; HDSS, Health and
Demographic Surveillance System.
Figure 2 Survey flow diagram for participant recruitment and inclusion. Sub-districts were defined as a cluster unit. In total, 32 clusters
were chosen as the study targets; eight clusters in Dodowa, 12 clusters in Kintampo, and 12 clusters in Navrongo. Half were allocated to the
intervention arm. HDSS; Health and Demographic Surveillance System.
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card to show that they complied with the CoC; this in-
cludes four ANC visits, delivery assisted by SBAs, and
three PNC visits (within 48 hours, at seven days, and at
six weeks after delivery). Additionally, health service pro-
viders record on the CoC card: provision of essential ser-
vices and health education; blood tests for assessing
hemoglobin, blood group, and Rhesus factor; intermit-
tent preventive treatment (IPT) for malaria; tetanus tox-
oid immunization; early initiating and exclusive
breastfeeding; family planning; preparing items for deliv-
ery and baby; arrangement of transportation for delivery,
caregiver, and calling health service providers after deliv-
ery; and the presence of danger signs during pregnancy
and after delivery for mother and newborn.
A-2 Continuum of care orientation
We will implement the MNCH CoC orientation in two
stages. First, we will complete the training of trainers for su-
pervisors of District Health Management Teams (DHMT)
and Sub-District Health Management Teams (SDHMT).
The trained supervisors will then conduct orientations for
health service providers at hospitals, health centers, CHPS,
and private clinics. We will focus mainly on introducing
MNCH CoC concepts, their importance, the extent to
which the MNCH CoC card could be used, and the proto-
cols of other interventions.
B-1 24-hour health facility retention of mothers and
newborns after delivery
In this intervention, we will encourage mothers to stay
with their newborns at health facilities after delivery for
at least 24 hours for PNC. This intervention targets only
the health facilities where SBAs provide delivery services.
In this intervention, mothers and newborns will receive
necessary care in a health facility during the 24 hours after
delivery. During their stay, we will provide them nutritious
drink supplements (for example, Milo (Nestlé S.A., Vevey,
Switzerland)). After ensuring all of the necessary health
Table 2 Interventions of Ghana EMBRACE implementation research project
Interventions Implementations Implementers Targets
(A-1) Utilization of CoC card Encourage mothers to receive four
ANC visits, facility delivery, PNC
within 48 hours, at 7 days, and at 6
weeks
Health service providers who
routinely provide MNCH at health
facility, community, or home: doctor,
midwife, nurse, CHO, and CHN
Women in prepartum/postpartum
period who come to the health
facility located in the intervention
arm for ANC, delivery, and PNC
(A-2) Orientation of health
service providers
Reorient supervisors in
understanding CoC
Master trainers from GHS/EMBRACE
researchers
Regional Health Administrations,
DHMT, and SDHMT
Reorient health service providers in
understanding CoC
Trainer from DHMT/SDHMT who
attended the training of trainers
Primary maternal and child health
service providers of the health
facilities in the intervention sites:
midwife, CHO, CHN, doctor, nurse,
and health assistant.
(B-1) 24-hour retention
of mother and their
newborns after delivery
Provide PNC within 48 hours by
retaining mothers with newborns for
at least 24-hours postpartum
Health service providers working at
district hospital, health center, CHPS
compound, or private clinic with
midwife
Mothers who delivered at a relevant
health facility and their newborns
(B-2) PNC by home visits Provide PNC within 48 hours by
visiting the home of mothers
Health service providers working at
health center or CHPS compound
Mothers who gave birth but did not
stay for 24 hours after delivery
Mothers who delivered at home and
their newborns
ANC, antenatal care; CHN, Community Health Nurse; CHO, Community Health Officer; CHPS, Community-based Health Planning and Service; CoC, Continuum of
Care; DHMT, District Health Management Team; SDHMT, Sub-District Health Management Team; GHS, Ghana Health Service; MNCH, maternal, newborn, and child
health; PNC, postnatal care.
Table 3 Maternal, newborn, and child health continuum
of care card contents
Contents Main components
CoC services Four ANC visits
Delivery with skilled birth attendant
Three PNC visits
Essential services Hemoglobin test
Malaria drug (IPT)
Tetanus toxoid immunization
Blood group and Rhesus factor
Health education Items for delivery and baby
Caregiver
Transportation for delivery
Call a health service provider after delivery
Early initiate and exclusive breast feeding
Family planning counselling
Danger signs Identification of danger signs during pregnancy
Identification of danger signs at delivery and
after delivery for mother
Identification of danger signs at birth and after
birth for newborn
ANC, antenatal care; CoC, Continuum of Care; IPT, Intermittent Preventive
Treatment; PNC, postnatal care.
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check points, health service providers will discharge them
if neither mothers nor babies show any danger signs.
B-2 Postnatal care by home visits
We will encourage CHOs to visit mothers and newborns
for PNC within 48 hours after delivery. This intervention
is composed of two steps. The first step is delivery noti-
fication; when home delivery occurs, community health
volunteers, community key informants, or traditional birth
attendants will inform the CHOs that the labor or delivery
occurred in the community. The second step is PNC by
home visits; CHOs visit mothers and newborns for PNC
within 48 hours postpartum.
Procurement
Where necessary, we will provide beds for postpartum
rest, rechargeable lamps or solar lanterns, torchlights for
all B-1 intervention facilities, and motorbikes for the B-2
intervention facilities. We will also provide care mate-
rials for both eligible categories of health facility such as
blood pressure apparatus for mothers and children,
stethoscopes, thermometers, and pen lights.
Supportive activities
We will organize three types of supportive activities be-
fore the start of the intervention to implement the inter-
ventions smoothly into the communities. They include
stakeholder meetings, community leader meetings, and
community durbars. We will organize the stakeholder
meetings in both the intervention and control arms. To
avoid contamination of the intervention effect, the com-
munity leader meetings and community durbars will be
held only in the intervention arm.
Monitoring
In each HRC, we will form an intervention monitoring
team. This team is responsible for monthly monitoring
of all implementation activities of health service providers
and for supervision of the DHMT/SDHMT supervisors.
The EMBRACE researchers will meet monthly to discuss
the issues raised during the monitoring and provide feed-
back to the monitoring team and the DHMT/SDHMT
supervisors.
Data collection
We will assess the impact of the intervention by inter-
view survey using a semi-structured questionnaire and
HDSS data. We will also assess the acceptability of the
implementation process by monthly monitoring and
supervision, and by conducting a survey of eligible
women at the HDSS sites. Data managers of the HRCs
will review all of the collected data for accuracy and
completion. Data will be entered into computers twice,
using Visual FoxPro software (Microsoft, Washington,
United States). Verification checks will be done to cor-
rect any discrepancies in records.
Evaluation of intervention efficacy
We will assess the intervention efficacy using both sur-
vey and HDSS data, as described below:
1. By survey: to assess the intervention impact, we
will conduct the interview survey at baseline and
follow-up periods for sampled eligible women. For
each survey, we will recruit approximately 500
women from each HDSS site (in total, 1,500 women
for each survey). We will select them through the
HRC pregnancy registers using the following two
steps: (a) creating geographical units (GU) in
proportion with the population size of the cluster
and selecting 50 GUs from each HDSS site, and
(b) selecting 10 eligible women from each GU.
We will select the GUs and women using
computer-generated random numbers.
The questionnaire items are: sociodemographic
and socioeconomic characteristics; MNCH services
uptake; health complications during pregnancy,
at delivery, and during postnatal period; pregnancy
outcomes; and care-seeking behaviors. To control
for the effects of health care provider and health
facility characteristics on the study outcome, we will
conduct health care provider assessment and health
facility assessment at the baseline survey for both
intervention and control arms. The data we will
collect includes information on service provision,
knowledge of CoC, supervision, community support,
job satisfaction at health care provider level,
infrastructure, human resources, MNCH service
availability, annual statistics of key MNCH
indicators, current practice of retaining mother
and newborn for the first 24 hours, and provision
of PNC by home visit within 48 hours postpartum.
Prior to the survey, we will complete training for
research assistants at each site. The EMBRACE
researchers will develop the survey questionnaire
through several workshops based on the formative
research questionnaire. We will develop the
questionnaire in English and the research assistants
will interpret it orally when they conduct interviews
with participants. As the local languages are not
always written, we will not use translated
questionnaires. The trained research assistants
will pre-test the questionnaire with 20 eligible
women and the researchers will revise it accordingly.
2. By HDSS data: we will also obtain the HDSS data to
assess the perinatal mortality rate (PMR) and the
neonatal mortality rate (NMR) of HDSS sites. We
will officially request that HRCs share the relevant
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data with the Ghana EMBRACE Implementation
Research Project.
Evaluation of implementation process acceptability
We will assess the acceptability of the implementation
process by monitoring, supervision, key informant inter-
views, and surveys, as described below:
1. By monitoring: to assess intervention adoption, we
will collect data about service provision through
monthly monitoring. Data sources will be the health
facility register book and District Health Information
Management System (DHIMS) reports. The
EMBRACE researchers developed the monitoring
items through several workshops.
2. By supervision: to assess intervention fidelity,
we will collect monthly supervision data to check
the consistency of intervention implementation.
3. By key informant interviews: we will conduct key
informant interviews among DHMT and SDHMT
supervisors, health service providers, and mothers
in the intervention arm.
4. By survey: we will ask about health education and
essential services provided to the women in the
baseline and follow-up surveys. We will ask women
in the intervention arm about service preferences
through the follow-up survey.
Outcome measures
Intervention outcome measures
The primary outcome of the intervention is CoC com-
pletion rate of mothers and their children (Figure 3
and Table 4). The secondary outcomes include the
PNC rate within 48 hours, the complication rate re-
quiring mothers’ and newborns' hospitalizations, and
the PMR and NMR. The PMR is defined as fetal
deaths during any period of pregnancy and newborn
deaths within seven completed days after birth. The
NMR includes early neonatal deaths occurring during
the first seven days of life and late neonatal deaths
occurring after seven days but before 28 completed
days of life [76,77].
Implementation outcome measures
The implementation outcomes will be measured by five
outcomes: 1) intervention coverage of target population,
2) adoption and 3) fidelity in CoC card utilization or PNC
within 48 hours by mothers’ retention at health facility or
by home visit, 4) implementation cost, and 5) sustainabil-
ity [64,78,79].
Sample size
We made a calculation for two types of sample size to
measure different outcomes. At first, to measure the
CoC completion rate, we used the interview survey
and calculated a total of 1,500 women for the sample
size. Second, to measure the NMR, we used a HDSS
data and calculated a total of 15,000 women for the
sample size.
To calculate the sample size of the CoC completion
rate, we used the data of the formative research col-
lected in the previous year in the same sites. Accord-
ing to the data, the CoC completion rate was 8.0%.
The coverage of four ANC visits, delivery attended by
SBAs, PNC within 48 hours postpartum, and PNC at two
weeks were 86.6%, 75.8%, 13.0%, and 60.0%, respectively.
The lowest coverage was identified at PNC within 48 hours
postpartum, and if this coverage increases to more than
that of PNC at two weeks, the CoC completion rate would
also increase to 60.0%. For that, we estimated that cover-
age of four ANC visits would be improved from 86.6 to
95.0%, and calculated the sample size using an intraclass
correlation coefficient (ICC) of 0.02675 determined in the
formative research. The ICC was estimated by considering
the differences in the sizes of clusters using multilevel
regression with a random intercept at the cluster level.
The confidence interval (CI) was 95%, and power was
80%. Adding 10% for potential attrition, the total sample
size was calculated at 1,500 for each baseline and
follow-up survey period. Therefore, we estimated
approximately a 500-person sample size for each HDSS
site (1,500 in total).
In addition to the interview survey, we will also use
the HDSS data to evaluate the effect of the interventions
on perinatal and neonatal mortality. For the baseline and
follow-up survey periods, HDSS data will capture 15,000
pregnancy cases, respectively. The sample size was esti-
mated according to the following assumptions: a 25% re-
duction of PMR (from 31 to 23 per 1,000 pregnancies),
with 95% CI, 80% power, 32 clusters, and an ICC of
0.0007256. The ICC was based on previous MNCH re-
search conducted in the study area [74] and the sample
size was calculated at 13,548. In addition, we added 10%
for potential attrition.
Statistical analysis
Continuum of care completion and morbidity
We will conduct baseline and follow-up interview surveys
to assess changes in each outcome in both the interven-
tion and control arms. To minimize overestimation of
intervention impact, we will estimate all intervention im-
pact outcomes with an intention-to-treat analysis. In this
analysis, individuals’ outcome data are analyzed according
to the allocated arm regardless of the place where they
received care. Also, all eligible individuals are included
in the analysis regardless of whether they provided out-
come data [80].
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We will conduct a descriptive analysis to assess the
distribution of various factors related to the mothers
and newborns under study. To evaluate the average ef-
fectiveness of interventions on CoC completion, we will
apply the generalized estimating equations model with
both continuous and binary outcomes [80]. This model
uses data on all mothers, including those with incom-
plete data, over the period from 16 weeks of pregnancy
to six weeks postpartum. Adjustment factors include
basic demographic characteristics, socioeconomic char-
acteristics, and facility characteristics. The data analysis
will mostly be conducted using Stata version 13 (Stata-
Corp LP, College Station, Texas, United States).
Mortality rate
PMR and NMR will be calculated based on the number
of live births and perinatal deaths or neonatal deaths as
a total of the three HDSS sites, as well as at each HDSS
site. These outcomes will be compared before and after
interventions.
Adoption of postnatal care within 48 hours and continuum
of care card utilization
Implementation impact will be evaluated by means of
descriptive statistical analysis. The qualitative data will
be coded and categorized.
Ethical considerations
Approval
Ethical approval was obtained from the Ethics Review
Committee of the GHS (reference: GHS-ERC: 13/03/14),
the Institutional Review Boards of Dodowa HRC (refer-
ence: FGS-DHRC: 280214), Kintampo HRC (reference:
2014–11), and Navrongo HRC (reference: NHRCIRB137)
in Ghana, and from the Research Ethics Committee of
the University of Tokyo in Japan (reference serial num-
ber: 10513).
Individual and community consent
Informed consent will be obtained from all survey par-
ticipants before their inclusion in the study. We will
record the consent through a signature or thumbprint.
Participants will be withdrawn from the study if they ex-
perience a serious or intolerable adverse event, develop
or disclose symptoms or conditions listed in the exclusion
criteria, or require early discontinuation for any other rea-
son. This will not affect their normal service delivery at
any of the health facilities.
Permission for conducting the intervention study will
be sought from the local health authorities and commu-
nity leaders before initiating the study.
Benefits and risks
This intervention package is not invasive. Thus, the
participants will not be exposed to marked risks. By
participating in this study, they benefit by improved CoC
knowledge and care of mothers and newborns. The
MNCH service providers will receive a training session
about CoC and the procedures to be performed. Health
facilities of the intervention arm will receive a set of
PNC services, motorbikes, or rest beds if they are not
available ones. We will introduce the intervention to the
Figure 3 Conceptual framework. The intervention package includes the utilization of the CoC card, CoC orientation for health service providers,
24-hour health facility retention of mothers and newborns after delivery, and home visit PNC. The outcomes will be measured for both
intervention and implementation aspects (ANC, antenatal care; CoC, Continuum of Care; NMR, neonatal mortality rate; PMR, perinatal mortality
rate; PNC, postnatal care).
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control arm participants immediately when a positive
impact is identified. We will encourage referral to a
health facility if we identify minor, acute, or chronic
illness in mothers or newborns in either the intervention
or control arms.
Confidentiality of information
All information obtained through this study will be
confidential. Access to information will be limited
to research assistants for conducting interviews and
data entry management staff. Study records will be
Table 4 Outcomes of Ghana EMBRACE implementation research project
Study objective Outcome variables Methods Data source
Intervention outcomes
To examine the effect
of the EMBRACE
interventions on CoC
completion
1) CoC completion rate Rate of mothers and their newborns
who completed CoC: ANC 4 visits,
delivery assisted by SBAs, PNC 3
times (within 48 hours, at 7 days, at
6 weeks postpartum)
Quantitative analysis Interview using semi-
structured questionnaire
Monitoring data
2) Rate of PNC within
48 hours
PNC rate of mothers and newborns
within 48 hours postpartum by 24
hours retention at health facility or
home visit
Quantitative analysis Interview using semi-
structured questionnaire
Monitoring data
To evaluate the impact
of the interventions on
MNCH status
3) Complication rate of
mothers and newborns
Complication rates which require
mothers’ and newborns’
hospitalizations for more than 24
hours
Quantitative analysis Interview using semi-
structured questionnaire
4) PMR and NMR PMR: fetal deaths during any period
of pregnancy and newborn death
within 7 completed days after birth.
Early NMR: neonatal deaths occurring
during the first 7 days of life.
Late NMR: neonatal deaths occurring
after 7 days but before 28 completed
days of life
Quantitative analysis HDSS data
Interview using semi-
structured questionnaire
Implementation outcomes
To evaluate the
acceptability of the
interventions in
different settings in
Ghana
1) Intervention
coverage
Percentage of women covered by
intervention
Quantitative analysis Interview using semi-
structured questionnaire
Monitoring data
2) Adoption Percentage and types of settings and
staff adopted in the intervention
Quantitative analysis Monitoring data
Qualitative summary of
key informant interviews
Supervision data
Notes from key informant
interview
3) Fidelity Adherence to the protocol and
quality of intervention delivery
Quantitative analysis Monitoring data
Qualitative summary of
key informant interviews
Monthly meeting of
project coordinators
Supervision data
Notes from key informant
interview
Discussion notes of
coordinators’ meetings
4) Implementation
cost
Direct measures of implementation
cost and additional expense of
implementation costs
Quantitative summary Costing format
5) Sustainability Institutionalization of interventions
or practice
Passage, cycle or routine, and niche
saturation
Discussions incorporating
results of intervention
research with project
supervisors
Discussion notes of project
meetings including district
health officer
Notes from key informant
interview with health
workers and district health
officers
Qualitative summary of
key informant interviews
ANC, antenatal care; CoC, Continuum of Care; HDSS, Health and Demographic Surveillance System; MNCH, maternal, newborn, and child health; NMR, neonatal
mortality rate; PMR, perinatal mortality rate; PNC, postnatal care; SBA, skilled birth attendant.
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identified only by means of study identification
numbers.
Dissemination of trial findings
The results of the study will be presented first to commu-
nity members and their leaders in HDSS sites. In addition,
policy briefs will be developed in collaboration with the
Policy, Planning, Monitoring, and Evaluation Division of
the GHS and submitted to the Office of the Director-
General of GHS and the Family Health Division. Presenta-
tions will be made at the GHS Directors meeting, the
Senior Managers Meeting, and international conferences.
Trial findings will also be disseminated in scientific
meetings and papers on the intervention impact on
improving CoC, the impact of increased CoC on MNCH
status, the acceptability of the interventions, and the
strategies for Japan's international health policy for
MNCH.
Discussion
This paper describes the protocol for a cluster random-
ized controlled trial to evaluate the impact of increased
CoC completion on MNCH status and the acceptability
of the interventions in different settings in Ghana. The
interventions will be implemented in close consultation
with local health administrative offices that have direct
responsibility for supervising health facilities. Ongoing
feedback will be provided through routine supervision.
Additionally, we developed the study materials in close
cooperation with policymakers in Ghana.
The study has limitations. First, the short intervention
period may limit the power to fully measure the interven-
tion and implementation impacts. The period is short be-
cause we needed repeated discussions to develop
intervention packages aimed at a sustainable and scalable
intervention design in a real-world setting. The project
takes into account the next scale-up phase which will
likely last years, during which the impacts could be
measured more accurately. To reduce this limitation, we
adopted the effectiveness-implementation hybrid trial that
is an advantageous study design for time efficiency that
enables rapid scaling of the intervention up to the national
MNCH service standard. Second, our intervention im-
pacts could be affected by previous or current projects
implemented at the HDSS sites. To minimize it, we will
control the potential effect for data analysis and carefully
discuss the study findings.
Trial status
The trial was registered in the International Standard Ran-
domized Controlled Trial Number Register on 3 September
2014 (ISRCTN90618993). Recruitment for intervention
commences in October 2014 and will continue until
September 2015.
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